Information
155 Sinseong-ro, Yuseong District, Daejeon, South Korea
+82 42-864-4462
-
-
Overview
- Summary
- Established in 1993, SELVAS Healthcare is a company providing digital healthcare and assistive technology devices through its medical device brand ACCUNIQ and ICT assistive technology brand HIMS. It offers a diverse product range including body composition analyzers, automatic blood pressure monitors, braille information terminals, and reading magnifiers. The company continuously innovates with advanced technology and products by integrating software and artificial intelligence (AI) data processing technologies from its affiliates.Established in 1993, SELVAS Healthcare is a company providing digital healthcare and assistive technology devices through its medical device brand ACCUNIQ and ICT assistive technology brand HIMS. It offers a diverse product range including body composition analyzers, automatic blood pressure monitors, braille information terminals, and reading magnifiers. The company continuously innovates with advanced technology and products by integrating software and artificial intelligence (AI) data processing technologies from its affiliates.
- Key Products/Technologies
- ACCUNIQ Brand Medical Diagnostic Devices: Body composition analyzers including ACCUNIQ BC720 (professional model, phase angle measurement, extracellular water ratio analysis, 6-frequency segmental body composition analysis), ACCUNIQ BC380 PLUS (multi-frequency phase angle measurement, segmental analysis of body water, muscle mass, water content, obesity analysis, nutrition, and cell health assessment), ACCUNIQ BC380 (segmental body fat and muscle mass analysis, body water balance assessment), ACCUNIQ BC300 (portable folding design, 10kg lightweight), and ACCUNIQ BC2000 (new product targeting the fitness and sports market, optimized for non-medical environments, enhanced data analysis and visualization for exercise-focused users, targeting Q3 2026 launch).ACCUNIQ Brand Medical Diagnostic Devices: Body composition analyzers including ACCUNIQ BC720 (professional model, phase angle measurement, extracellular water ratio analysis, 6-frequency segmental body composition analysis), ACCUNIQ BC380 PLUS (multi-frequency phase angle measurement, segmental analysis of body water, muscle mass, water content, obesity analysis, nutrition, and cell health assessment), ACCUNIQ BC380 (segmental body fat and muscle mass analysis, body water balance assessment), ACCUNIQ BC300 (portable folding design, 10kg lightweight), and ACCUNIQ BC2000 (new product targeting the fitness and sports market, optimized for non-medical environments, enhanced data analysis and visualization for exercise-focused users, targeting Q3 2026 launch).
- ACCUNIQ Brand Medical Diagnostic Devices: Automatic electronic blood pressure monitors including ACCUNIQ BP850 (world's first FDA-approved dual-arm blood pressure monitor, utilized for early detection of cardiovascular diseases like stroke and heart attack through dual-arm measurement), and various models such as ACCUNIQ BP650, BP600, BP250, BP210, BP500. These devices feature automatic blood pressure and pulse measurement with a single operation, and technology to minimize measurement errors by detecting subtle arm movements. The company also provides solutions for automatic data linkage from blood pressure monitors (BP Monitor) and air quality monitors (AQM) to EMR systems, minimizing human error and reducing medical staff's documentation burden.ACCUNIQ Brand Medical Diagnostic Devices: Automatic electronic blood pressure monitors including ACCUNIQ BP850 (world's first FDA-approved dual-arm blood pressure monitor, utilized for early detection of cardiovascular diseases like stroke and heart attack through dual-arm measurement), and various models such as ACCUNIQ BP650, BP600, BP250, BP210, BP500. These devices feature automatic blood pressure and pulse measurement with a single operation, and technology to minimize measurement errors by detecting subtle arm movements. The company also provides solutions for automatic data linkage from blood pressure monitors (BP Monitor) and air quality monitors (AQM) to EMR systems, minimizing human error and reducing medical staff's documentation burden.
- HIMS Brand ICT Assistive Technology Devices: Braille information terminals including HanSonE 7 (BrailleSense 7, next-generation AI braille terminal, tactile-based design, proprietary ART (Active Responsive Touch) technology combining physical braille display with touch sensing, integrated with Google's AI model Gemini, supporting cloud and on-device AI functions), HanSonE 6 MINI, HanSonE 6, and HanSonE 5 (BrailleSense Polaris, Google Mobile Service Device certified).HIMS Brand ICT Assistive Technology Devices: Braille information terminals including HanSonE 7 (BrailleSense 7, next-generation AI braille terminal, tactile-based design, proprietary ART (Active Responsive Touch) technology combining physical braille display with touch sensing, integrated with Google's AI model Gemini, supporting cloud and on-device AI functions), HanSonE 6 MINI, HanSonE 6, and HanSonE 5 (BrailleSense Polaris, Google Mobile Service Device certified).
- HIMS Brand ICT Assistive Technology Devices: Low vision magnifiers such as Candy, SenseView Vision, SenseView Vision Pro, and Magnilink (offering features like automatic movement of near/far screens, print character recognition, document magnification, file viewer, and USB storage). Audio readers like BookMaru and BookMaru3 have been developed and released.HIMS Brand ICT Assistive Technology Devices: Low vision magnifiers such as Candy, SenseView Vision, SenseView Vision Pro, and Magnilink (offering features like automatic movement of near/far screens, print character recognition, document magnification, file viewer, and USB storage). Audio readers like BookMaru and BookMaru3 have been developed and released.
- Software Solutions: ACCUNIQ Connect for body composition management, ACCUNIQ Dashboard for customer management, ACCUNIQ BP Connect for blood pressure measurement data management, and ACCUNIQ BP Monitor for hospital blood pressure measurement data management. Development of the National Institute of Korean Language's braille translation software, JeomSarang 6.0.Software Solutions: ACCUNIQ Connect for body composition management, ACCUNIQ Dashboard for customer management, ACCUNIQ BP Connect for blood pressure measurement data management, and ACCUNIQ BP Monitor for hospital blood pressure measurement data management. Development of the National Institute of Korean Language's braille translation software, JeomSarang 6.0.
- Core Advantages
- Hardware and AI/Software Convergence Technology: The company possesses advanced technological capabilities, combining its existing medical device hardware development expertise with software and AI data processing technologies from its affiliates. This integration, leveraging Selvas AI's medical voice recognition and medical image recognition AI technologies, expands possibilities for personalized real-time remote medical care and communication between doctors and patients.Hardware and AI/Software Convergence Technology: The company possesses advanced technological capabilities, combining its existing medical device hardware development expertise with software and AI data processing technologies from its affiliates. This integration, leveraging Selvas AI's medical voice recognition and medical image recognition AI technologies, expands possibilities for personalized real-time remote medical care and communication between doctors and patients.
- Global Market Competitiveness and Export Share: Overseas sales account for over 60% of total revenue, and the company has been selected for the 'Global Strong Small and Medium-sized Enterprises 1000+ Project,' receiving up to 2 billion KRW in R&D support. It has secured a high-level personal information protection system compliant with international standards in heavily regulated markets such as Europe and North America.Global Market Competitiveness and Export Share: Overseas sales account for over 60% of total revenue, and the company has been selected for the 'Global Strong Small and Medium-sized Enterprises 1000+ Project,' receiving up to 2 billion KRW in R&D support. It has secured a high-level personal information protection system compliant with international standards in heavily regulated markets such as Europe and North America.
- Diverse Product Portfolio and Market Expansion: A dual-brand strategy with medical diagnostic devices 'ACCUNIQ' and assistive technology devices 'HIMS' ensures a broad customer base. The company is actively expanding its business from traditional medical institutions to the fitness and wellness markets, and is vigorously pursuing the development of new AI-based remote medical and AI medical diagnostic products.Diverse Product Portfolio and Market Expansion: A dual-brand strategy with medical diagnostic devices 'ACCUNIQ' and assistive technology devices 'HIMS' ensures a broad customer base. The company is actively expanding its business from traditional medical institutions to the fitness and wellness markets, and is vigorously pursuing the development of new AI-based remote medical and AI medical diagnostic products.
- International Certifications and Awards: Simultaneous acquisition of ISO 27001 (International Standard for Information Security Management Systems) and ISO 27701 (International Standard for Privacy Information Management Systems). The ACCUNIQ automatic electronic blood pressure monitor product line has completed clinical trials under the international standard ISO 81060-2:2018/Amd 1:2020, internationally recognizing the accuracy and reproducibility of its products. The next-generation AI braille terminal 'BrailleSense 7' received a main award in the product category at the 'iF Design Award 2026,' securing design excellence.International Certifications and Awards: Simultaneous acquisition of ISO 27001 (International Standard for Information Security Management Systems) and ISO 27701 (International Standard for Privacy Information Management Systems). The ACCUNIQ automatic electronic blood pressure monitor product line has completed clinical trials under the international standard ISO 81060-2:2018/Amd 1:2020, internationally recognizing the accuracy and reproducibility of its products. The next-generation AI braille terminal 'BrailleSense 7' received a main award in the product category at the 'iF Design Award 2026,' securing design excellence.
- Strategic Joint Venture Establishment and Investment: Establishment of 'Selvas Invision Co., Ltd.' as a joint venture with UltraSight, a global AI cardiac ultrasound company, to develop AI cardiac ultrasound solutions and target the Asian market. Participation in the capital increase of Mediana Co., Ltd. to secure equity, aiming to become the largest AI medical innovation company in Korea in conjunction with Selvas AI.Strategic Joint Venture Establishment and Investment: Establishment of 'Selvas Invision Co., Ltd.' as a joint venture with UltraSight, a global AI cardiac ultrasound company, to develop AI cardiac ultrasound solutions and target the Asian market. Participation in the capital increase of Mediana Co., Ltd. to secure equity, aiming to become the largest AI medical innovation company in Korea in conjunction with Selvas AI.
- Target Industrie
- Medical Institutions (hospitals, clinics, etc.)Medical Institutions (hospitals, clinics, etc.)
- Fitness and Wellness Market (gyms, sports centers, etc.)Fitness and Wellness Market (gyms, sports centers, etc.)
- Rehabilitation Assistive Technology Sector (for visually impaired individuals, etc.)Rehabilitation Assistive Technology Sector (for visually impaired individuals, etc.)
- Remote Health Management and AI Medical Diagnosis MarketRemote Health Management and AI Medical Diagnosis Market
- Public Institutions (Ministry of National Defense smart medical system)Public Institutions (Ministry of National Defense smart medical system)
- Major Markets
- India, China, Japan, Taiwan, ThailandIndia, China, Japan, Taiwan, Thailand
- Europe-wideEurope-wide
- United StatesUnited States
- AustraliaAustralia
- Certifications/Patents
- Acquisition of ISO 27001 (International Standard for Information Security Management Systems) and ISO 27701 (International Standard for Privacy Information Management Systems) simultaneously.Acquisition of ISO 27001 (International Standard for Information Security Management Systems) and ISO 27701 (International Standard for Privacy Information Management Systems) simultaneously.
- ACCUNIQ automatic electronic blood pressure monitor product line completed ISO 81060-2:2018/Amd 1:2020 international clinical trial certification (including 6 products such as BP500, BP501, BP503, ACCUNIQ BP600, ACCUNIQ BP650, ACCUNIQ BP651, ACCUNIQ BP653).ACCUNIQ automatic electronic blood pressure monitor product line completed ISO 81060-2:2018/Amd 1:2020 international clinical trial certification (including 6 products such as BP500, BP501, BP503, ACCUNIQ BP600, ACCUNIQ BP650, ACCUNIQ BP651, ACCUNIQ BP653).
- Acquisition of patent rights related to a body composition analysis device and server that provide personalized information based on body composition changes and user records.Acquisition of patent rights related to a body composition analysis device and server that provide personalized information based on body composition changes and user records.
- Acquisition of a patent related to a portable video magnification device (to be utilized for advanced low vision products).Acquisition of a patent related to a portable video magnification device (to be utilized for advanced low vision products).
- Acquisition of patent rights related to a human impedance measurement method and device utilizing it.Acquisition of patent rights related to a human impedance measurement method and device utilizing it.
- Acquisition of patent rights for a braille terminal for the visually impaired (technology for detecting user finger movements and automatic braille conversion).Acquisition of patent rights for a braille terminal for the visually impaired (technology for detecting user finger movements and automatic braille conversion).
- Braille information terminal HanSonE 5 (BrailleSense Polaris) obtained Google GMS (Google Mobile Service) Device certification.Braille information terminal HanSonE 5 (BrailleSense Polaris) obtained Google GMS (Google Mobile Service) Device certification.
- Selvas Invision's AI cardiac ultrasound received digital medical device certification (2025).Selvas Invision's AI cardiac ultrasound received digital medical device certification (2025).
Introduction
Location
155 Sinseong-ro, Yuseong District, Daejeon, South Korea
클릭하여 위치 살펴보기
